Shopping Cart
- Remove All
- Your shopping cart is currently empty
Leucettine L41 (LeucettineL41) is a selective DYRK1A inhibitor that inhibits DYRK2, CLK1, and CLK3, inducing autophagy linked to CLK inhibition. It is used to study Alzheimer's disease and memory deficits.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $81 | In Stock | |
5 mg | $198 | In Stock | |
10 mg | $373 | In Stock | |
25 mg | $616 | In Stock | |
50 mg | $872 | In Stock |
Description | Leucettine L41 (LeucettineL41) is a selective DYRK1A inhibitor that inhibits DYRK2, CLK1, and CLK3, inducing autophagy linked to CLK inhibition. It is used to study Alzheimer's disease and memory deficits. |
Targets&IC50 | Dyrk2:0.035 µM, Dyrk1A:0.04 µM, CLK1:0.015 µM, CLK3:4.5 µM |
In vitro | Leucettine L41 is a potent inhibitor of bispecic tyrosine phosphorylated regulated kinase 1A (DYRK1A), DYRK2, CDC-like kinase 1 (CLK1), and CLK3 with IC50 of 0.04, 0.035, 0.015, and 4.5 µM, respectively. Leucettine L41 inhibits phosphorylation of serine/arginine-rich protein (SRp). [1] |
In vivo | Leucettine L41(0.4, 1.2, 4 μg) prevented Aβ25-35-induced hippocampal memory impairment and neurotoxicity in mice. [2] Leucettine L41(20 mg/kg, peritoneal injection) AAV-AD rat model showed decreased soluble P-tau form but unchanged soluble Aβ42 level. [4] |
Alias | LeucettineL41 |
Molecular Weight | 307.3 |
Formula | C17H13N3O3 |
Cas No. | 1112978-84-3 |
Smiles | C(\C=1C=C2C(=CC1)OCO2)=C/3\NC(NC4=CC=CC=C4)=NC3=O |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80.00 mg/mL (260.33 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.